What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Drug Discovery Clinical Trial Clinical Development

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1339255

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1339255

Leprosy Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class ; By Disease Type; By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032

PUBLISHED: July 23, 2023

PAGES: 112 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The global Leprosy Treatment market size is expected to reach USD 5,000.33 million by 2032, according to a new study by Polaris Market Research. The report "Leprosy Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Antibacterial, Leprostatics, Sulfone, Phenazine, Anti-tubercular Drugs, and Others); By Disease Type; By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The demand for leprosy treatment is growing more quickly due to the increasing incidence of skin diseases. The prevalence of skin conditions like psoriasis and leprosy has increased in nations like China and India, which has fueled the market. According to the World Health Organization, around 120 countries have leprosy cases, and more than 200,000 cases are reported yearly. Hundreds of millions of people have skin NTDs.

Additionally, leprosy, an NTD, hurts the standard of living of mainly marginalized populations in remote rural areas and causes immense discomfort, suffering, stigmatization, and mental distress. The prevalence of high occurrences provides that some regions of the world experience both high incidence and high transmission rates. In the past 20 years, the WHO estimates that approximately 16 million leprosy cases have been treated. Therefore, the rising prevalence of skin disease and NTD prevalence has increased the demand for leprosy treatment, driving the market's growth over the forecast period.

As per the WHO, the number of people needing interventions for NTDs has fallen by 25% over the past ten years, by about 80 million people between 2020 and 2021. Additionally, there is a consistent decline in the disease burden measured in years of life with a disability. Between 2016 and 2019, more than one billion individuals received treatment annually. By the end of 2022, 47 nations had eliminated at least one NTD.

However, the COVID-19 pandemic severely affected NTD programs, which resulted in a decrease in the implementation of community-based interventions, a restriction on access to services provided by healthcare facilities, and negative effects on the supply chains for medical supplies, disrupting this promising trend. As a result, between 2019 and 2020, 34% fewer people were treated for NTDs.

Leprosy Treatment Market Report Highlights

The injectable route of administration segment is anticipated to grow at a significant CAGR over the forecast period owing to the drug of first preference for treating leprosy being dapsone.

Anti-tubercular drugs are expected to hold a significant market share over the forecast period due to drugs such as Rifampin treating both TB and leprosy.

Asia-Pacific is expected to grow at a considerable CAGR over the projected period on account of the rising disease prevalence as well as the government programs to support the treatment.

The global players include: Astra Zeneca, Bayer, GSK, Johnson & Johnson, Merck, Pfizer Inc., Systopic Laboratories, Sanofi, and Teva Pharmaceutical.

Polaris Market Research has segmented the Leprosy Treatment market report based on drug class, route of administration, disease type, distribution channel, and region:

Leprosy Treatment, Drug Class Outlook (Revenue - USD Million, 2019 - 2032)

Antibacterial
Leprostatics
Sulfone
Phenazine
Anti-tubercular Drugs
Others

Leprosy Treatment, Route of Administration Outlook (Revenue - USD Million, 2019 - 2032)

Oral
Injectable
Topical

Leprosy Treatment, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)

Paucibacillary Leprosy
Multibacillary Leprosy

Leprosy Treatment, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies

Leprosy Treatment, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa

Product Code: PM3635

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Leprosy Treatment Market Insights

4.1. Leprosy Treatment - Industry Snapshot
4.2. Leprosy Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Technological advancement
  - 4.2.1.2. Increasing use of Leprosy Treatment technology in healthcare
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Increasing digitization will restrict the market growth
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Leprosy Treatment Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Leprosy Treatment Market, by Drug Class

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
5.3. Antibacterial
- 5.3.1. Global Leprosy Treatment Market, by Antibacterial, by Region, 2019-2032 (USD Million)
5.4. Leprostatics
- 5.4.1. Global Leprosy Treatment Market, by Leprostatics, by Region, 2019-2032 (USD Million)
5.5. Sulfone
- 5.5.1. Global Leprosy Treatment Market, by Sulfone, by Region, 2019-2032 (USD Million)
5.6. Phenazine
- 5.6.1. Global Leprosy Treatment Market, by Phenazine, by Region, 2019-2032 (USD Million)
5.7. Anti-tubercular Drugs
- 5.7.1. Global Leprosy Treatment Market, by Anti-tubercular Drugs, by Region, 2019-2032 (USD Million)
5.8. Others
- 5.8.1. Global Leprosy Treatment Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Leprosy Treatment Market, by Disease Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
6.3. Paucibacillary Leprosy
- 6.3.1. Global Leprosy Treatment Market, by Paucibacillary Leprosy, by Region, 2019-2032 (USD Million)
6.4. Multibacillary Leprosy
- 6.4.1. Global Leprosy Treatment Market, by Multibacillary Leprosy, by Region, 2019-2032 (USD Million)

7. Global Leprosy Treatment Market, by Route of Administration

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
7.3. Oral
- 7.3.1. Global Leprosy Treatment Market, by Oral, by Region, 2019-2032 (USD Million)
7.4. Injectable
- 7.4.1. Global Leprosy Treatment Market, by Injectable, by Region, 2019-2032 (USD Million)
7.5. Topical
- 7.5.1. Global Leprosy Treatment Market, by Topical, by Region, 2019-2032 (USD Million)

8. Global Leprosy Treatment Market, by Distribution Channel

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
8.3. Hospital Pharmacies
- 8.3.1. Global Leprosy Treatment Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Million)
8.4. Retail Pharmacies
- 8.4.1. Global Leprosy Treatment Market, by Retail Pharmacies, by Region, 2019-2032 (USD Million)
8.5. Drug Stores
- 8.5.1. Global Leprosy Treatment Market, by Drug Stores, by Region, 2019-2032 (USD Million)
8.6. Online Pharmacies
- 8.6.1. Global Leprosy Treatment Market, by Online Pharmacies, by Region, 2019-2032 (USD Million)

9. Global Leprosy Treatment Market, by Geography

9.1. Key findings
9.2. Introduction
- 9.2.1. Leprosy Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
9.3. Leprosy Treatment Market - North America
- 9.3.1. North America: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 9.3.2. North America: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.3.3. North America: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
- 9.3.4. North America: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.3.5. Leprosy Treatment Market - U.S.
  - 9.3.5.1. U.S.: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.3.5.2. U.S.: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.3.5.3. U.S.: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.3.5.4. U.S.: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.3.6. Leprosy Treatment Market - Canada
  - 9.3.6.1. Canada: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.3.6.2. Canada: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.3.6.3. Canada: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.3.6.4. Canada: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
9.4. Leprosy Treatment Market - Europe
- 9.4.1. Europe: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 9.4.2. Europe: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.4.3. Europe: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
- 9.4.4. Europe: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.4.5. Leprosy Treatment Market - UK
  - 9.4.5.1. UK: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.4.5.2. UK: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.4.5.3. UK: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.4.5.4. UK: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.4.6. Leprosy Treatment Market - France
  - 9.4.6.1. France: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.4.6.2. France: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.4.6.3. France: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.4.6.4. France: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.4.7. Leprosy Treatment Market - Germany
  - 9.4.7.1. Germany: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.4.7.2. Germany: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.4.7.3. Germany: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.4.7.4. Germany: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.4.8. Leprosy Treatment Market - Italy
  - 9.4.8.1. Italy: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.4.8.2. Italy: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.4.8.3. Italy: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.4.8.4. Italy: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.4.9. Leprosy Treatment Market - Spain
  - 9.4.9.1. Spain: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.4.9.2. Spain: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.4.9.3. Spain: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.4.9.4. Spain: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.4.10. Leprosy Treatment Market - Netherlands
  - 9.4.10.1. Netherlands: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.4.10.2. Netherlands: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.4.10.3. Netherlands: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.4.10.4. Netherlands: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.4.11. Leprosy Treatment Market - Russia
  - 9.4.11.1. Russia: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.4.11.2. Russia.: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.4.11.3. Russia: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.4.11.4. Russia: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
9.5. Leprosy Treatment Market - Asia Pacific
- 9.5.1. Asia Pacific: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 9.5.2. Asia Pacific: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.5.3. Asia Pacific: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
- 9.5.4. Asia Pacific: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.5.5. Leprosy Treatment Market - China
  - 9.5.5.1. China: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.5.5.2. China.: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.5.5.3. China: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.5.5.4. China: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.5.6. Leprosy Treatment Market - India
  - 9.5.6.1. India: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.5.6.2. India.: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.5.6.3. India: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.5.6.4. India: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.5.7. Leprosy Treatment Market - Japan
  - 9.5.7.1. Japan: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.5.7.2. Japan.: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.5.7.3. Japan: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.5.7.4. Japan: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.5.8. Leprosy Treatment Market - Malaysia
  - 9.5.8.1. Malaysia: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.5.8.2. Malaysia.: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.5.8.3. Malaysia: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.5.8.4. Malaysia: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.5.9. Leprosy Treatment Market - Indonesia
  - 9.5.9.1. Indonesia: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.5.9.2. Indonesia.: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.5.9.3. Indonesia: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.5.9.4. Indonesia: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.5.10. Leprosy Treatment Market - South Korea
  - 9.5.10.1. South Korea: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.5.10.2. South Korea.: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.5.10.3. South Korea: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.5.10.4. South Korea: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
9.6. Leprosy Treatment Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 9.6.2. Middle East & Africa: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.6.3. Middle East & Africa: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
- 9.6.4. Middle East & Africa: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.6.5. Leprosy Treatment Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.6.5.2. Saudi Arabia: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.6.5.3. Saudi Arabia: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.6.5.4. Saudi Arabia: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.6.6. Leprosy Treatment Market - South Africa
  - 9.6.6.1. South Africa: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.6.6.2. South Africa: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.6.6.3. South Africa: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.6.6.4. South Africa: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.6.7. Leprosy Treatment Market - Israel
  - 9.6.7.1. Israel: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.6.7.2. Israel: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.6.7.3. Israel: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.6.7.4. Israel: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.6.8. Leprosy Treatment Market - UAE
  - 9.6.8.1. UAE: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.6.8.2. UAE: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.6.8.3. UAE: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.6.8.4. UAE: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
9.7. Leprosy Treatment Market - Latin America
- 9.7.1. Latin America: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
- 9.7.2. Latin America: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
- 9.7.3. Latin America: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
- 9.7.4. Latin America: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.7.5. Leprosy Treatment Market - Mexico
  - 9.7.5.1. Mexico: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.7.5.2. Mexico: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.7.5.3. Mexico: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.7.5.4. Mexico: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.7.6. Leprosy Treatment Market - Brazil
  - 9.7.6.1. Brazil: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.7.6.2. Brazil: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.7.6.3. Brazil: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.7.6.4. Brazil: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
- 9.7.7. Leprosy Treatment Market - Argentina
  - 9.7.7.1. Argentina: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
  - 9.7.7.2. Argentina: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  - 9.7.7.3. Argentina: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
  - 9.7.7.4. Argentina: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11.1. Acme Pharmaceuticals
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Astra Zeneca
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Bayer
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Bristol-Myers
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Cadila Pharmaceuticals
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Eli Lily
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Genetic Pharma
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. GSK
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. IDPL
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Johnson & Johnson
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Lark Laboratories
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Merck
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13.Macleods Pharmaceuticals
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Novartis
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
11.15. Pfizer
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
11.16. Systopic Laboratories
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Benchmarking
- 11.16.4. Recent Development
11.17. Sanofi
- 11.17.1. Company Overview
- 11.17.2. Financial Performance
- 11.17.3. Product Benchmarking
- 11.17.4. Recent Development
11.18. Teva Pharmaceutical
- 11.18.1. Company Overview
- 11.18.2. Financial Performance
- 11.18.3. Product Benchmarking
- 11.18.4. Recent Development

Product Code: PM3635

List of Tables

Table 1 Global Leprosy Treatment Market, by Drug Class, by Region, 2019-2032 (USD Million)
Table 2 Global Leprosy Treatment Market, by Disease Type, by Region, 2019-2032 (USD Million)
Table 3 Global Leprosy Treatment Market, by Route of Administration, by Region, 2019-2032 (USD Million)
Table 4 Global Leprosy Treatment Market, by Distribution Channel, by Region, 2019-2032 (USD Million)
Table 5 Leprosy Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
Table 6 North America: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 7 North America: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 8 North America: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 9 North America: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 10 U.S.: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 11 U.S.: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 12 U.S.: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 13 U.S.: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 14 Canada: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 15 Canada: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 16 Canada: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 17 Canada: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 18 Europe: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 19 Europe: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 20 Europe: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 21 Europe: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 22 Germany: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 23 Germany: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 24 Germany: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 25 Germany: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 26 France: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 27 France: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 28 France: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 29 France: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 30 UK: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 31 UK: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 32 UK: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 33 UK: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 34 Italy: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 35 Italy: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 36 Italy: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 37 Italy: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 38 Netherlands: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 39 Netherlands: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 40 Netherlands: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 41 Netherlands: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 42 Spain: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 43 Spain: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 44 Spain: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 45 Spain: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 46 Russia: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 47 Russia: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 48 Russia: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 49 Russia: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 50 Asia Pacific: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 51 Asia Pacific: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 52 Asia Pacific: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 53 Asia Pacific: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 54 China: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 55 China: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 56 China: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 57 China: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 58 Japan: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 59 Japan: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 60 Japan: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 61 Japan: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 62 India: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 63 India: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 64 India: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 65 India: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 66 Indonesia: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 67 Indonesia: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 68 Indonesia: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 69 Indonesia: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 70 Malaysia: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 71 Malaysia: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 72 Malaysia: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 73 Malaysia: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 74 South Korea: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 75 South Korea: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 76 South Korea: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 77 South Korea: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 78 Latin America: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 79 Latin America: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 80 Latin America: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 81 Latin America: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 82 Brazil: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 83 Brazil: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 84 Brazil: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 85 Brazil: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 86 Mexico: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 87 Mexico: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 88 Mexico: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 89 Mexico: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 90 Argentina: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 91 Argentina: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 92 Argentina: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 93 Argentina: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 94 Middle East & Africa: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 95 Middle East & Africa: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 96 Middle East & Africa: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 97 Middle East & Africa: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 98 UAE: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 99 UAE: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 100 UAE: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 101 UAE: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 102 Saudi Arabia: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 103 Saudi Arabia: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 104 Saudi Arabia: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 105 Saudi Arabia: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 106 South Africa: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 107 South Africa: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 108 South Africa: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 109 South Africa: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
Table 110 Israel: Leprosy Treatment Market, by Drug Class, 2019-2032 (USD Million)
Table 111 Israel: Leprosy Treatment Market, by Disease Type, 2019-2032 (USD Million)
Table 112 Israel: Leprosy Treatment Market, by Route of Administration, 2019-2032 (USD Million)
Table 113 Israel: Leprosy Treatment Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

Figure 1. Global Leprosy Treatment Market, 2019-2032 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Distribution Channel
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Drug Class
Figure 7. Global Leprosy Treatment Market, by Drug Class, 2021 & 2030 (USD Million)
Figure 8. Market by Distribution Channel
Figure 9. Global Leprosy Treatment Market, by Distribution Channel, 2021 & 2030 (USD Million)
Figure 10. Market by Disease Type
Figure 11. Global Leprosy Treatment Market, by Disease Type, 2021 & 2030 (USD Million)
Figure 12. Market by Route of Administration
Figure 13. Global Leprosy Treatment Market, by Route of Administration, 2021 & 2030 (USD Million)